Covıd-19, Coronavirus

Covıd-19, Coronavirus

AstraZeneca, Johnson & Johnson COVID-19 vaccine trials back on track in US

AstraZeneca, Johnson & Johnson COVID-19 vaccine trials back on track in US

24/10/2020 4:53:00 AM

AstraZeneca, Johnson & Johnson COVID-19 vaccine trials back on track in US

WASHINGTON: Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States on Friday (Oct 23), providing a ...

BookmarkWASHINGTON: Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States on Friday (Oct 23), providing a glimmer of hope as the number of cases skyrockets across the country.COVID-19 has now killed more than 223,000 Americans, and the health crisis is a top issue in the presidential election pitting incumbent Donald Trump against Joe Biden.

Argentina football legend Maradona dies of heart attack Argentinian football legend Diego Maradona dies at 60 US surpasses 2,000 COVID-19 deaths in a day, with hospitals already full

AdvertisementAdvertisementAstraZeneca announced that the trial of its vaccine candidate, developed with Britain's University of Oxford, has resumed in the US, the only country where it remained suspended following a participant's illness six weeks ago.

"The Food and Drug Administration (FDA) today authorised the restart in the US, following the resumption of trials in other countries in recent weeks," the drugmaker said.The trial was suspended worldwide on Sep 6, but resumed shortly thereafter in Britain, and in the following weeks in South Africa, Brazil and Japan, with authorities determining the illness was not apparently linked to the vaccine.

AdvertisementAdvertisement"The FDA reviewed all safety data from trials globally and concluded it was safe to resume the trial," AstraZeneca said.The company added it was hoping to have results later this year,"depending on the rate of infection within the communities where the clinical trials are being conducted".

The AstraZeneca vaccine project is one of the most promising and advanced in the world to combat the global pandemic, which has now claimed the lives of 1.1 million people.It is one of 10 vaccine candidates being tested on tens of thousands of people in so-called phase 3 trials.

AdvertisementIn the United States, the two top candidates vying to get a green light from the FDA are those made by Pfizer and Moderna. Both expect to request approval next month.Many countries are counting on using the AstraZeneca vaccine to inoculate their populations.

The drugmaker pre-sold hundreds of millions of doses on several continents and signed partnership deals with other producers to ensure the doses could be made locally.READ: Scientists raise alarm over signs of COVID-19 vaccine 'hesitancy'"NO EVIDENCE" VACCINE CAUSED ILLNESS

Malaysia proposes changes to KL-S'pore High Speed Rail project, S'pore remains committed to fulfilling obligations: MOT Argentine football genius Maradona saw heaven and hell Thai protesters call on king to give up royal fortune

Shortly after AstraZeneca's announcement, Johnson & Johnson said it was preparing to resume recruitment for its parallel trial, which was suspended last week after a volunteer fell ill."After a thorough evaluation of a serious medical event experienced by one study participant, no clear cause has been identified," the group said in a statement.

"The company has found no evidence that the vaccine candidate caused the event."Just before Friday's announcements, a top US official involved with Operation Warp Speed, the government's vaccine initiative, said he expected the J&J trial to resume quickly.

READ: COVID-19 vaccine may be ready by year-end: WHO's TedrosPaul Mango, from the US Department of Health and Human Services, also said he expected the country to have enough doses on hand to vaccinate the"most vulnerable" Americans before year's end.

Read more: CNA »

Grace Fu on why she hopes to be a climate change champion | EP 14

She took over the newly formed Ministry of Sustainability and the Environment in July. Four months into her new role, Ms Fu talks to Jaime Ho about why sustainability will be at the heart of government policies and why shifting towards sustainability is less of a choice than a necessity for Singapore today.

Australia's Covid-19 hotspot Victoria sees active Covid-19 cases fall to 4-month lowVictoria state recorded just one new infection in the past 24 hours.. Read more at

AstraZeneca, Oxford allowed to resume Covid-19 vaccine trial in USAstraZeneca's large, late-stage US trial has been on hold since Sept 6, after a participant in the UK trial fell ill.. Read more at

WHO: Nations mulling Gilead's COVID-19 drug should consider trial flop, tooThe World Health Organization is preparing its guidelines on the use of the drug remdesivir to treat COVID-19 , and should be able to release it in ...

WHO's Tedros says countries on 'dangerous track' in COVID-19 pandemicThe world is now at a critical juncture in the COVID-19 pandemic and some countries are on a dangerous path, facing the prospect of health ... Tedros' was leader of TPLF terrorist group that rained violence on Ethiopians As health minister he covered up epidemics. As Foreign minister he cracked down on journalists & political opposition He continues his deceit as WHO chief. Can Tedros be trusted? Thanks for nothing, how is he still leading the WHO? Haven’t we suffered this fool long enough? Start an inquiry and look for a non-CCP shill and competent replacement stat!

Puerto Rico shutters 911 call centers amid COVID-19 casesPuerto Rico shutters 911 call centers amid coronavirus cases

China to maintain ban on outbound tours due to COVID-19 riskSHANGHAI: China will continue to suspend outbound group tours and ban travel agencies from allowing inbound tours due to the risk of a resurgence ...